Free Research Report Download:
The Cancer Market Outlook To 2014
Free Pharmaceutical Market Research Reports
Corporate & Fiscal
Pharmaceutical Events & Conferences
Terms & Conditions
Countries covered include India, China and Republic of Korea.
Data for key companies in these countries include Name and Therapeutic Class of Biosimilars Developed, List of Marketed Biologics, Biosimilars in Pipeline, Manufacturing Capacity, Expertise in Biopharmaceutical technology and Investment Details
Key players in India include Intas Biopharmaceuticals Ltd., Dr. Reddy?s Laboratories Ltd., Reliance Life Sciences Pvt. Ltd, Zenotech Laboratories Limited, Inbiopro Solutions Pvt. Ltd.USV Limited, Biocon Limited, and Zydus Cadilla Healthcare Limited, among others
Key players in China include GeneScience Pharmaceuticals Co., Ltd., Shenyang Sunshine Pharmaceutical Company Limited, Shandong GeneLeuk Biopharmaceutical Co.,ltd., Beijing SL Pharmaceutical Co., Ltd, Shanghai Huaxin High Biotechnology Inc., 3SBio Inc., and China National Biotec Group among others
Key players in Republic of Korea include LG Life Sciences, Ltd, Celltrion, Inc., Dong-A Pharmaceutical Co., Ltd, Genexine Co., Ltd., and Green Cross Corporation among others
Reasons to Buy
Develop business strategies by understanding the trends and developments that are driving the orthopedic devices market in the emerging countries.
Design and develop your biosimilars development, marketing and sales strategies in India, China and Republic of Korea.
Exploit M&A opportunities by identifying market players with the most innovative biosimilar in pipeline in these countries.
Identify key players best positioned to take advantage of emerging market opportunities.
Exploit in-licensing and out-licensing opportunities by identifying products which are most likely to ensure a robust return.